A Study of Nivolumab Combined With Ipilimumab Versus Nivolumab Alone in Participants With Advanced Kidney Cancer
Clinical trial NCT03873402 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03873402
- Sponsor
- Bristol-Myers Squibb
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-06-21
- Primary completion
- 2027-03-11
- Enrollment
- 437
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.